Latisse™

You may have read about LATISSE^TM in any number of newspapers or magazines, heard about it on the news, and even seen it mentioned in a few blogs. NBC 10 Health Check reporter Barbara Morse Silva in Providence, Rhode Island interviewed Dr. Leonard and spoke with one of his own patients using LATISSE^TM.  Click here to watch the news segment.

Everyone is talking about this first-only FDA approved treatment for hypotrichosis of eyelashes (inadequate or not enough eyelashes). Whether you've heard of LATISSE^TM within the context of beauty, anti-aging, or even medical breakthroughs, you can be sure that the exciting discussions around this new treatment will continue in the coming months and years to come.

While it was originally developed as a glaucoma medication, one of the side effects noted by patients was a thickening and lengthening of the upper eye lashes, prompting the makers of the treatment to study it for a different use. In clinical tests, LATISSE^TM was proven to enhance eyelash prominence in length, thickness, and darkness.

Now FDA approved, this once-daily treatment is applied to the base of the upper eyelashes (like eyeliner) with a sterile, single use-per-eye disposable applicator. Patients can experience longer, fuller, darker eyelashes in as little as eight weeks, with significant results in 16 weeks.

The treatment is only available through a prescription from a doctor.